Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2013 /
DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

3rd - 6th Nov 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.11.13
Views: 3262

Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK

Dr Gavin talks to ecancertv at the UK's National Cancer Research Institute ( NCRI ) 2013 meeting about a study looking at the effects of prostate cancer treatment comparing the Republic of Ireland with Northern Ireland, UK.

There are differences in services such as testing, leading to 30% more diagnosis in the ROI than Northern Ireland; in some cases overdiagnosis.

The team carried out a postal survey of men diagnosed with prostate cancer, receiving 3300 replies with very useful quality of life information leaving us in a better position to inform men about the treatment options associated with prostate cancer.



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation